Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 15560501000001113 | Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 53204901000001116 | Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for infusion 250ml bottles | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Intravenous route | true | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solutioninfusion.intravenous ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has active ingredient | Sodium amidotrizoate | false | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has active ingredient | Meglumine amidotrizoate | false | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has manufactured dose form | Solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Is a | Product containing meglumine diatrizoate and sodium diatrizoate | false | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has active ingredient | Sodium amidotrizoate | false | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has active ingredient | Meglumine amidotrizoate | false | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Is a | Meglumine amidotrizoate + Sodium amidotrizoate | true | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has manufactured dose form | Conventional release solution for infusion | false | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has specific active ingredient | Meglumine amidotrizoate | true | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has specific active ingredient | Sodium amidotrizoate | true | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has dispensed dose form | Conventional release solution for infusion | true | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Has manufactured dose form | Conventional release solution for infusion | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Urografin 150 solution for infusion 250ml bottles (Schering Health Care Ltd) | Is a | True | Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Inferred relationship | Existential restriction modifier | |
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles 1 bottle | Is pack of | False | Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Inferred relationship | Existential restriction modifier | |
| Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles 1 bottle | Has VMP | True | Meglumine amidotrizoate 260mg/ml / Sodium amidotrizoate 40mg/ml (Iodine 150mg/ml) solution for injection 250ml bottles | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR